Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres
- PMID: 20207626
- DOI: 10.1093/hmg/ddq098
Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disorder characterized by ptosis, dysphagia and proximal limb weakness. Autosomal-dominant OPMD is caused by a short (GCG)(8-13) expansions within the first exon of the poly(A)-binding protein nuclear 1 gene (PABPN1), leading to an expanded polyalanine tract in the mutated protein. Expanded PABPN1 forms insoluble aggregates in the nuclei of skeletal muscle fibres. In order to gain insight into the different physiological processes affected in OPMD muscles, we have used a transgenic mouse model of OPMD (A17.1) and performed transcriptomic studies combined with a detailed phenotypic characterization of this model at three time points. The transcriptomic analysis revealed a massive gene deregulation in the A17.1 mice, among which we identified a significant deregulation of pathways associated with muscle atrophy. Using a mathematical model for progression, we have identified that one-third of the progressive genes were also associated with muscle atrophy. Functional and histological analysis of the skeletal muscle of this mouse model confirmed a severe and progressive muscular atrophy associated with a reduction in muscle strength. Moreover, muscle atrophy in the A17.1 mice was restricted to fast glycolytic fibres, containing a large number of intranuclear inclusions (INIs). The soleus muscle and, in particular, oxidative fibres were spared, even though they contained INIs albeit to a lesser degree. These results demonstrate a fibre-type specificity of muscle atrophy in this OPMD model. This study improves our understanding of the biological pathways modified in OPMD to identify potential biomarkers and new therapeutic targets.
Similar articles
-
Intranuclear Aggregates Precede Clinical Onset in Oculopharyngeal Muscular Dystrophy.J Neuromuscul Dis. 2016 Mar 3;3(1):101-109. doi: 10.3233/JND-150118. J Neuromuscul Dis. 2016. PMID: 27854203
-
Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.Acta Neuropathol. 2022 Dec;144(6):1157-1170. doi: 10.1007/s00401-022-02503-7. Epub 2022 Oct 5. Acta Neuropathol. 2022. PMID: 36197469 Free PMC article.
-
Established PABPN1 intranuclear inclusions in OPMD muscle can be efficiently reversed by AAV-mediated knockdown and replacement of mutant expanded PABPN1.Hum Mol Genet. 2019 Oct 1;28(19):3301-3308. doi: 10.1093/hmg/ddz167. Hum Mol Genet. 2019. PMID: 31294444 Free PMC article.
-
Progress in understanding the pathogenesis of oculopharyngeal muscular dystrophy.Can J Neurol Sci. 2003 Feb;30(1):8-14. doi: 10.1017/s0317167100002365. Can J Neurol Sci. 2003. PMID: 12619777 Review.
-
Oculopharyngeal muscular dystrophy: recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies.Biochim Biophys Acta. 2007 Feb;1772(2):173-85. doi: 10.1016/j.bbadis.2006.10.003. Epub 2006 Oct 11. Biochim Biophys Acta. 2007. PMID: 17110089 Review.
Cited by
-
Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis.PLoS One. 2012;7(4):e35273. doi: 10.1371/journal.pone.0035273. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22530000 Free PMC article.
-
A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.Aging (Albany NY). 2013 Jun;5(6):412-26. doi: 10.18632/aging.100567. Aging (Albany NY). 2013. PMID: 23793615 Free PMC article.
-
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients.Skelet Muscle. 2011 Apr 4;1(1):15. doi: 10.1186/2044-5040-1-15. Skelet Muscle. 2011. PMID: 21798095 Free PMC article.
-
PABPN1: molecular function and muscle disease.FEBS J. 2013 Sep;280(17):4230-50. doi: 10.1111/febs.12294. Epub 2013 May 24. FEBS J. 2013. PMID: 23601051 Free PMC article. Review.
-
Over-expression of BCL2 rescues muscle weakness in a mouse model of oculopharyngeal muscular dystrophy.Hum Mol Genet. 2011 Mar 15;20(6):1154-63. doi: 10.1093/hmg/ddq559. Epub 2011 Jan 3. Hum Mol Genet. 2011. PMID: 21199860 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases